Physician profile
William Michael Shimp
NPI 1821092511
$4,089.04
in general payments reported to CMS, 2019-2025
11 companies · $870 in 2025
The $870 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $596 · 2023: $1,321 · 2024: $1,102 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,601.53 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Getinge USA Sales, LLC | $942.09 | 2023-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardioroot |
| Edwards Lifesciences Corporation | $568.59 | 2021-2024 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $523.97 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Abiomed | $283.04 | 2025 | |
| Kls-Martin L.P. | $52.89 | 2022-2023 | |
| Kci USA, INC. | $38.93 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Cardiovascular Systems INC. | $20.75 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.66 | 2022 | |
| Solventum Corporation | $19.90 | 2024 | Prevena |
| Endologix LLC | $16.69 | 2024 | Afx2 Bifurcated Endograft System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Shimp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.